Clinical Scorecard: The Relationship Between Insulin Resistance, Systemic Vascular Resistance, and Isolated Diastolic Hypertension: A Metabolic Perspective on a Neglected Hypertension Phenotype

At a Glance

Key Highlights

• IDH is characterized by elevated diastolic blood pressure with systolic blood pressure below hypertension thresholds.
• Prevalence of IDH is higher in younger populations and declines with age.
• IDH is associated with increased systemic vascular resistance and preserved large-artery compliance.
• Insulin resistance and compensatory hyperinsulinemia are linked to IDH risk.
• Guideline definitions for IDH vary, impacting prevalence and risk assessment.

Guideline-Based Recommendations

Diagnosis

• Use ambulatory blood pressure monitoring (ABPM) or home blood pressure monitoring (HBPM) for confirmation.

Management

• Consider metabolic status in managing IDH and explore specific treatment options.

Monitoring & Follow-up

• Monitor for cardiovascular events and metabolic risk factors.

Risks

• IDH is associated with adverse cardiovascular events, particularly in younger populations.

Patient & Prescribing Data

Young and middle-aged adults with isolated diastolic hypertension.

Pragmatic insulin resistance surrogates may aid in risk stratification.

Clinical Best Practices

• Integrate hemodynamic and metabolic characterization for precision management.
• Utilize multiple measurements to confirm IDH diagnosis due to potential measurement errors.

Related Resources & Content

• ACC/AHA Guidelines
• ESC/ESH Guidelines